PINE Pharmaceuticals will be exhibiting at booth #1407 this weekend at the ASCRS•ASOA Symposium & Congress in New Orleans. This will be the company’s first time participating and it will also feature the debut of PINE Pharmaceuticals’ newest product, TROPIcamide-PHENylephrine, to leading practitioners in Ophthalmology.
TROPIcamide-PHENylephrine is available without patient names or prescriptions and is a compounded solution of Phenylephrine HCl 2.5% – Tropicamide 1% in a 15 mL dropper bottle. As a compounded preparation, TROPIcamide-PHENylephrine affords clinicians the option using a single bottle.
PINE Pharmaceuticals representatives will be available to answer questions at booth #1407 during the ASCRS•ASOA Symposium & Congress on May 7th, 8th & 9th.
The ASCRS•ASOA Symposium & Congress is the largest U.S. meeting that integrates scientific programs with leading practice management programs for comprehensive ophthalmology and sub-specialties. Attendees will have the opportunity to learn directly from the world’s thought leaders in ophthalmology, broaden networking connections, and return with the practical tools needed to improve their practice.